GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Total Liabilities

NKGen Biotech (NKGen Biotech) Total Liabilities : $71.37 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech Total Liabilities?

NKGen Biotech's Total Liabilities for the quarter that ended in Mar. 2024 was $71.37 Mil.

NKGen Biotech's quarterly Total Liabilities increased from Sep. 2023 ($65.84 Mil) to Dec. 2023 ($75.17 Mil) but then declined from Dec. 2023 ($75.17 Mil) to Mar. 2024 ($71.37 Mil).

NKGen Biotech's annual Total Liabilities declined from Dec. 2021 ($56.12 Mil) to Dec. 2022 ($14.77 Mil) but then increased from Dec. 2022 ($14.77 Mil) to Dec. 2023 ($75.17 Mil).

NKGen Biotech Total Liabilities Historical Data

The historical data trend for NKGen Biotech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech Total Liabilities Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
Total Liabilities
56.12 14.77 75.17

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial 14.77 - 65.84 75.17 71.37

NKGen Biotech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

NKGen Biotech's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=39.452+(9.93+25.759
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0.033+0)
=75.17

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=16.481--58.693
=75.17

NKGen Biotech's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=37.483+(10.495+23.36
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0.033+0)
=71.37

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=16.316--55.055
=71.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NKGen Biotech Total Liabilities Related Terms

Thank you for viewing the detailed overview of NKGen Biotech's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

NKGen Biotech (NKGen Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Total Liabilities
Comparable Companies
OCUP CASI SPRO XLO NGM GBIO ASMB CCCC OCEA FIXX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
Website
https://www.nkgenbiotech.com
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.